Drug Manufacturers - Specialty & Generic: 40 U.S.-Listed Stocks by Market Cap
EquiReason covers 40 U.S.-listed companies in the Drug Manufacturers - Specialty & Generic industry (Healthcare sector), with a combined market cap of $179.3B. The largest by market cap: Zoetis Inc. (ZTS, $33.5B), United Therapeutics Corporation (UTHR, $25.2B), Viatris Inc. (VTRS, $20.7B), Neurocrine Biosciences, Inc. (NBIX, $14.5B), Elanco Animal Health Incorporated (ELAN, $11.3B).
Sector and industry classification and market cap at the latest close: EquiReason company data · financial statements on each company's page come from its SEC filings
Companies by market cap
| # | Company | Market cap |
|---|---|---|
| 1 | ZTS Zoetis Inc. | $33.5B |
| 2 | UTHR United Therapeutics Corporation | $25.2B |
| 3 | VTRS Viatris Inc. | $20.7B |
| 4 | NBIX Neurocrine Biosciences, Inc. | $14.5B |
| 5 | ELAN Elanco Animal Health Incorporated | $11.3B |
| 6 | ALKS Alkermes plc | $7.3B |
| 7 | LNTH Lantheus Holdings, Inc. | $6.5B |
| 8 | AMRX Amneal Pharmaceuticals, Inc. | $6.5B |
| 9 | HIMS Hims & Hers Health, Inc. | $6.5B |
| 10 | KNSA Kiniksa Pharmaceuticals International, plc | $6.0B |
| 11 | INDV Indivior Pharmaceuticals, Inc. | $4.1B |
| 12 | LQDA Liquidia Corporation | $3.8B |
| 13 | RGC Regencell Bioscience Holdings Ltd | $3.8B |
| 14 | AMLX Amylyx Pharmaceuticals, Inc. | $3.0B |
| 15 | SUPN Supernus Pharmaceuticals, Inc. | $2.4B |
| 16 | PBH Prestige Consumer Healthcare Inc. | $2.3B |
| 17 | PRGO Perrigo Company plc | $2.2B |
| 18 | TRLV Trulieve Cannabis Corp. | $2.0B |
| 19 | BCRX BioCryst Pharmaceuticals, Inc. | $2.0B |
| 20 | XERS Xeris Biopharma Holdings, Inc. | $1.9B |
| 21 | ANIP ANI Pharmaceuticals, Inc. | $1.7B |
| 22 | PAHC Phibro Animal Health Corporation | $1.6B |
| 23 | PCRX Pacira BioSciences, Inc. | $1.5B |
| 24 | ETON Eton Pharmaceuticals, Inc. | $1.4B |
| 25 | CRON Cronos Group Inc. | $1.2B |
| 26 | AMPH Amphastar Pharmaceuticals, Inc. | $1.1B |
| 27 | HROW Harrow, Inc. | $1.1B |
| 28 | COLL Collegium Pharmaceutical, Inc. | $747.5M |
| 29 | IRWD Ironwood Pharmaceuticals, Inc. | $570.1M |
| 30 | AQST Aquestive Therapeutics, Inc. | $502.0M |
| 31 | EOLS Evolus, Inc. | $463.0M |
| 32 | TLRY Tilray Brands, Inc. | $415.3M |
| 33 | EBS Emergent BioSolutions Inc. | $319.4M |
| 34 | ANIK Anika Therapeutics, Inc. | $286.7M |
| 35 | CGC Canopy Growth Corp | $285.9M |
| 36 | BIOA BioAge Labs, Inc. | $234.1M |
| 37 | SIGA SIGA Technologies, Inc. | $224.2M |
| 38 | GLAS Glass House Brands Inc. | $185.1M |
| 39 | AKBA Akebia Therapeutics, Inc. | $157.1M |
| 40 | ORGO Organogenesis Holdings Inc. | $127.8M |
Questions
- What are the largest drug manufacturers - specialty & generic stocks?
- By market cap: Zoetis Inc. (ZTS) $33.5B, United Therapeutics Corporation (UTHR) $25.2B, Viatris Inc. (VTRS) $20.7B, Neurocrine Biosciences, Inc. (NBIX) $14.5B, Elanco Animal Health Incorporated (ELAN) $11.3B, Alkermes plc (ALKS) $7.3B, Lantheus Holdings, Inc. (LNTH) $6.5B, Amneal Pharmaceuticals, Inc. (AMRX) $6.5B, Hims & Hers Health, Inc. (HIMS) $6.5B, Kiniksa Pharmaceuticals International, plc (KNSA) $6.0B.
- How many drug manufacturers - specialty & generic companies are listed in the U.S.?
- EquiReason covers 40 U.S.-listed companies in this industry; the full list is above.
How these figures are read: methodology · EquiReason.